Neuromuscular disease (NMD)

NMD is a broad term that encompasses many diseases and ailments that impair the functioning of the muscles either directly via intrinsic muscle pathology, or indirectly via nerve pathology.

Some NMD patients are characterised by progressive muscular impairment leading to:

Loss of mobility, being wheelchair-bound, swallowing difficulties, respiratory muscle weakness, death from respiratory failure.

Neuromuscular disorders can be divided into rapidly progressive and slowly progressive:

Rapidly progressive disorders are characterised by muscle impairment that worsens over months, and results in death within a few years (eg, amyotrophic lateral sclerosis (ALS) and Duchenne muscular dystrophy (DMD) in teenagers).

Variable or slowly progressive disorders are characterised by muscle impairment that worsens over years and only mildly reduces life expectancy (eg, limb girdle, facioscapulohumeral and myotonic muscular dystrophy).

NMD treatment options

NMD treatment options

Treating a patient with respiratory failure caused by NMD can help alleviate some of the symptoms of poor respiration.

ResMed’s neuromuscular disease solutions

ResMed’s NIV with a leak circuit and a volume-assurance target are designed to reduce PtcCO2 in neuromuscular disease patients.

ResMed’s neuromuscular disease solutions

ResMed’s neuromuscular disease solutions

ResMed’s NIV with a leak circuit and a volume-assurance target are designed to reduce PtcCO2 in neuromuscular disease patients.

NMD patient outcomes

NMD patient outcomes

Learn the benefits of treating NMD patients with NIV.